Miguel Tejeda

Miguel Tejeda

National Institute of Oncology, Hungary - Budapest / Hungary
Others
AD Scientific Index ID: 4411777
-
person_outline Miguel Tejeda's MOST POPULAR ARTICLES
1-) A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity.G Kéri, J Erchegyi, A Horvath, I Mezo, M Idei, T Vantus, A Balogh, ...Proceedings of the National Academy of Sciences 93 (22), 12513-12518, 19961521996
2-) Development of an oxime bond containing daunorubicin-gonadotropin-releasing hormone-III conjugate as a potential anticancer drugI Szabó, M Manea, E Orbán, A Csámpai, S Bosze, R Szabó, M Tejeda, ...Bioconjugate chemistry 20 (4), 656-665, 2009772009
3-) Enhanced enzymatic stability and antitumor activity of daunorubicin-GnRH-III bioconjugates modified in position 4M Manea, U Leurs, E Orban, Z Baranyai, P Öhlschläger, A Marquardt, ...Bioconjugate chemistry 22 (7), 1320-1329, 2011422011
4-) The antitumor activity of the somatostatin structural derivative (TT-232) on different human tumor xenografts.M Tejeda, D Gaal, K Barna, O Csuka, G KériAnticancer research 23 (5A), 4061-4066, 2003282003
5-) Antiproliferative efficacy of the somatostatin analogue TT-232 in human melanoma cells and tumours.RE Schwab, S Froidevaux, S Paku, M Tejeda, B Szende, A Pap, ...Anticancer research 21 (1A), 71-75, 2001272001